Vanguard Capital Management
TMCI icon

Vanguard Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Vanguard Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.07M Buy
2,028,479
+566,972
+39% +$1.56M ﹤0.01% 2939
2026
Q1 		$1.96M Buy
+1,461,507
New +$2.91M ﹤0.01% 3371

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management's TMCI Position: Q2 2026 in Review

Vanguard Capital Management increased its Treace Medical Concepts (TMCI) stake by 39% in Q2 2026, buying an estimated $1.56M and bringing the position to 2,028,479 shares worth $8.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2939.

Vanguard Capital Management first reported a position in TMCI in Q1 2026 and has held it in 2 quarters since. 107 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Vanguard Capital Management held 2,028,479 shares of Treace Medical Concepts worth $8.07M as of Q2 2026.
  • Vanguard Capital Management bought 566,972 Treace Medical Concepts shares in Q2 2026, an estimated $1.56M.
  • Treace Medical Concepts made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2939 holding.
  • Vanguard Capital Management first reported a position in Treace Medical Concepts in Q1 2026 and has held it in 2 quarters since.
  • 107 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.